Acute poisoning is a serious threat to society and one of the commonest causes of mortality and morbidity. The purpose of this study was to have an idea about the pattern of corrosive poisoning and their socio-demographic background. This study was conducted in Dhaka Medical College Hospital over a period of six months from January to June, 2008. The total respondents were 126 in number. All patients, aged 13 years and above with acute corrosive poisoning were included. The results revealed that 23% were male and 77% female. Male, female ratio was 1: 3.34. Age between (13-30) years (88.09%) was the most vulnerable. Most of the patients (45.25%) had a background of secondary education. Students (43.7%) were the dominant group followed by housewives (30.2%). Most of the patients (80.2%) came from urban area. 88.9% attempted to commit suicide. Familial disharmony (75.4%) was the leading motive of poisoning. Twenty five types of corrosive agents were identified; out of which 83.34% cases took either Savlon (51.59%) or Harpic (31.75%). Female is the most vulnerable target who attempted to commit suicide. DOI: http://dx.doi.org/10.3329/bmj.v42i3.19000 Bangladesh Med J. 2013 Sept; 42 (3): 78-81
Background Stroke is the second leading cause of mortality worldwide; where the majority of stroke is ischemic. Among ischemic stroke, cardio-embolic has both higher severity and mortality. Objective To find out clinical outcomes and determine predictors of mortality related to cardio-embolic stroke. Methodology This prospective cohort study was conducted among patients of acute ischemic stroke of cardiac origin admitted at the National Institute of Neurosciences and Hospital, Bangladesh from 1 st October 2020 to 30 September, 2021. Patients were kept under follow-up to 90 days from discharge. Results A total of 689 ischemic stroke patients were screened, 156 had confirmed Cardio-embolic stroke. So, the frequency of cardio-embolic stroke was 22.64%. Male to female ratio was 1.3:1, mean age of 63 years. Hypertension 119 (76.3%), atrial fibrillation 107 (68.6%), and IHD 40 (25.6%) were most common comorbidities. Interestingly, we found only 23 (14.7%) patients with chronic rheumatic heart diseases. NIH Stroke scale score (median, IQR) during admission was 13 [7- 19]. Overall mortality was 47 (29.9%), among them 30 (19.2%) died within 48 hours of hospital admission while 17 (10.9%) within 90 days of hospital discharge. Modified Rankin score at 90 days was 2 [min 0, max 5] those who survived. Cumulative incidence of recurrent stroke was 9 (7.1%) and incidence of anticoagulant induced hemorrhage were 5 (3.2%) among them. Risk factors associated with mortality (odds ratio, [95% CI], p value) were acute myocardial infarction (1.6 [1.14 – 2.52] , 0.04), raised Troponin (1.89 [1.16-2.99], 0.01), reduced ejection fraction (3.38 [2.17-5.27], <0.001), hypotension (3.12 [2.07 – 4.68], < 0.001), chronic kidney disease (1.82 [1.06 - 3.10], 0.04), raised Creatinine (2.41 [1.52 -3.84], 0.01), raised blood sugar ( 1.82 [1.14 - 2.89], 0.02) , severe stroke (9.45 [3.57 – 25.03] , <0.001), large infarct (53.67 [7.59 - 379.47] , < 0.001), hemorrhagic transformation (4.43 [2.89 – 6.84] , < 0.001) and aspiration pneumonia (1.9 [1.28-2.39], 0.01) . Conclusion Overall frequency, severity, functional disability, and mortality in cardio-embolic stroke are higher. Acute myocardial infarction, severe stroke, presence of hyperglycemia, hypotension, renal impairment, low ejection fraction, large infarct, hemorrhagic transformations, and aspiration pneumonia are both clinically and statistically significantly associated with mortality in cardio-embolic stroke.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.